[Brachytherapy of 125I implantation for localized prostate cancer (report of 41 cases)].
OBJECTIVE
To observe the effect of brachytherapy of 125I implantation on localized prostate cancer.


METHODS
Two-step technique was engaged in the implantation of 125I into the prostate for 41 localized prostate cancer patients. The prescription dosage of 125I was 160 Gy. TRUS and C-Arm X-ray were used for the confirmation of seeds location in the prostate.


RESULTS
Thirty-three patients were followed up for 3 to 4 years. Abnormal PSAs were found in 2 patients by positive biopsy. No patients died in this investigation. The early stage complications were urinary irritation symptoms that were severe within 6 months and disappeared after 1 year.


CONCLUSIONS
Brachytherapy of 125I implantation increases long-term tumor-free survival rate, with few long-term complications and some short-tern urinary stimulating symptoms.
Bai
Qiang
Q
Department of Urology, Affiliated Renji Hospital, Shanghai Second Medical University, Shanghai 200001, China. qiangbai@eyou.com
Wang
Yixin
Y
Kaye
Keith W
KW
D000368:Aged; D000369:Aged, 80 and over; D001918:Brachytherapy / Q000009:adverse effects / Q000379:methods; D006801:Humans; D007457:Iodine Radioisotopes / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D011471:Prostatic Neoplasms / Q000401:mortality / Q000532:radiotherapy*; D015996:Survival Rate
D007457:Iodine Radioisotopes